Doxychel Hyclate en es it fr

Doxychel Hyclate Brand names, Doxychel Hyclate Analogs

Doxychel Hyclate Brand Names Mixture

  • No information avaliable

Doxychel Hyclate Chemical_Formula

C22H24N2O8

Doxychel Hyclate RX_link

http://www.rxlist.com/cgi/generic/doxycyc.htm

Doxychel Hyclate fda sheet

Doxychel_Hyclate FDA

Doxychel Hyclate msds (material safety sheet)

Doxychel_Hyclate MSDS

Doxychel Hyclate Synthesis Reference

C. R. Stephens et al.; J. Am. Chem. Soc. 80; 5324 (1958)

Doxychel Hyclate Molecular Weight

444.435 g/mol

Doxychel Hyclate Melting Point

201 oC

Doxychel Hyclate H2O Solubility

630 mg/L

Doxychel Hyclate State

Solid

Doxychel Hyclate LogP

-1.219

Doxychel Hyclate Dosage Forms

Tablet; Capsule; Gel; Liquid; Powder; Powder for solution

Doxychel Hyclate Indication

For the treatment of the following infections:Rocky mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers caused by Rickettsiae, Chancroid caused by Haemophilus ducreyi, Uncomplicated gonorrhea caused by Neisseria gonorrhoeae, Respiratory tract infections caused by Mycoplasma pneumoniae or Streptococcus pneumoniae. Lymphogranuloma ve

Doxychel Hyclate Pharmacology

Doxycycline, a long-acting tetracycline derived from oxytetracycline, is used to inhibit bacterial protein synthesis and treat non-gonococcal urethritis and cervicitis, exacerbations of bronchitis in patients with COPD, and adult periodontitis.

Doxychel Hyclate Absorption

completely absorbed after oral administration

Doxychel Hyclate side effects and Toxicity

anorexia, nausea, diarrhoea, glossitis, dysphagia, enterocolitis and inflammatory lesions (with monilial overgrowth) in the anogenital region. skin reactions such as maculopapular and erythematous rashes, exfoliative dermatitis, photosensitivity, hypersensitivity reactions such as urticaria, angioneurotic oedema, anaphylaxis, anaphyl-actoid purpura, pericarditis, and exacerbation of systemic lupus erythematosus, benign intracranial hypertension in adults disappearing on discontinuation of the medicine, haematologic abnormalities such as haemolytic anaemia, thrombocytopenia, neutropenia, and eosinophilia. LD50=262 mg/kg(i.p. in rat)

Doxychel Hyclate Patient Information

Doxychel Hyclate Organisms Affected

Enteric bacteria and other eubacteria